SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-027185
Filing Date
2024-03-28
Accepted
2024-03-28 16:01:52
Documents
83
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0201339-10k_tffpharma.htm   iXBRL 10-K 1315619
2 CONSENT OF MARCUM LLP ea0201339ex23-1_tffpharma.htm EX-23.1 2127
3 CERTIFICATION ea0201339ex31-1_tffpharma.htm EX-31.1 11025
4 CERTIFICATION ea0201339ex31-2_tffpharma.htm EX-31.2 11393
5 CERTIFICATION ea0201339ex32-1_tffpharma.htm EX-32.1 5290
6 TFF PHARMACEUTICALS, INC. EXECUTIVE OFFICER CLAWBACK POLICY ea0201339ex97-1_tffpharma.htm EX-97.1 57747
7 GRAPHIC image_001.jpg GRAPHIC 3174
8 GRAPHIC image_002.jpg GRAPHIC 31140
  Complete submission text file 0001213900-24-027185.txt   6251048

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE tffp-20231231.xsd EX-101.SCH 62779
10 XBRL CALCULATION FILE tffp-20231231_cal.xml EX-101.CAL 31303
11 XBRL DEFINITION FILE tffp-20231231_def.xml EX-101.DEF 265323
12 XBRL LABEL FILE tffp-20231231_lab.xml EX-101.LAB 488206
13 XBRL PRESENTATION FILE tffp-20231231_pre.xml EX-101.PRE 265731
87 EXTRACTED XBRL INSTANCE DOCUMENT ea0201339-10k_tffpharma_htm.xml XML 707194
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39102 | Film No.: 24798697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)